Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classement en actions #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Prix de l'action
$59.98
Dernière synchronisation: 2024-12-13
Capitalisation boursière
$1.22B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Longboard Pharmaceuticals, Inc. (LBPH)

Catégorie

Healthcare
Revenus pour Longboard Pharmaceuticals, Inc. (LBPH)
Revenus en Sep 2024 TTM : $8.00K
Selon les derniers rapports financiers de Longboard Pharmaceuticals, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $8.00K. En 2022, l'entreprise a réalisé un chiffre d'affaires de 0.00 égal à le chiffre d'affaires de l'année 2021, qui était de 0.00. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Longboard Pharmaceuticals, Inc. de 2020 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $8.00K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 157,803,650.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 75,265,991.36%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 196,803,989.28%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 27,849,900.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH